Editor in Chief @BioCentury. Dr, the Ph.D-type. Biotech innovation & breaking barriers, one woman at a time. Views are mine, hope to make them yours too.
Joined January 2012
- Tweets 5,297
- Following 1,190
- Followers 3,270
- Likes 6,295
234 Photos and videos
6 Jan 2025
Kicking off 2025 by leaving this platform pretty much for good. Come on over and find me at the other place. @fishburnsimone.bsky.social. You can find there my message to biotechs for the new year. Also on Linkedin linkedin.com/in/simonefishbu….
2
261
5 Nov 2024
So often I hear, “my vote doesn’t make a difference- I’m in a blue/red state.” Not true. The Iowa poll shows that. States change when people turn up. Don’t leave your fate - or democracy - to others.
Vote.
4
531
28 Oct 2024
I'll be at @fishburnsimone.bsky.social. Come on over.
28 Oct 2024
Before I fully go to @bluesky, a message for everywhere:
VOTE. Vote like it matters, because it does. Get other people to vote. And most of all, take your kids to vote. Not less important than soccer practice, baseball games or Halloween. Vote.
429
28 Oct 2024
Before I fully go to @bluesky, a message for everywhere:
VOTE. Vote like it matters, because it does. Get other people to vote. And most of all, take your kids to vote. Not less important than soccer practice, baseball games or Halloween. Vote.
2
601
2 Oct 2024
And so, with heavy hearts we enter this Jewish New Year. And with more uncertainty and sadness than we have collectively felt for decades. But still the inevitable hope that this will mark a pivot to better days - wishing those who mark it, a good, healthy and peaceful Shana Tova
2
4
387
30 Sep 2024
There's a long-standing discussion about whether research should be hypothesis-driven or hypothesis free. Omics are making unbiased discovery more realistic and industry is opening up to that. But academic incentives aren't aligned. @_Ktktktktk discusses: biocentury.com/article/65370…
1
4
426
26 Sep 2024
I had a fantastic conversation too! @johnvoyler occupies a rare position in biotech of having built a $20B company in under 15 years. Some of his lessons, via the podcast (available also on Apple, Spotify and more).
26 Sep 2024
I had a fantastic conversation with @FishburnSimone on the @BioCentury podcast. Thank you for having me as a guest. I truly enjoyed discussing @BeiGeneGlobal's global growth strategy and sharing insights about our innovative pipeline. Full podcast here: youtube.com/watch?v=dkdHRHkT…
299
Simone Fishburn 🎗️ retweeted
23 Sep 2024
Our Co-Founder, Chairman and CEO, @johnvoyler, recently joined @FishburnSimone on the @BioCentury podcast. They delved into BeiGene's corporate global growth and our innovative pipeline. Tune in to the show to discover more: bit.ly/4ez5BH4
1
2
342
Simone Fishburn 🎗️ retweeted
25 Sep 2024
The value in mapping genetics to the medical phenome: case studies from @VanderbiltU. Nancy Cox discusses insights from longitudinal EHRs, biobank data, and their value to drug developers: a BioCentury Q&A buff.ly/3ZDWUaA
2
2
842
Simone Fishburn 🎗️ retweeted
19 Sep 2024
John Oyler’s long game at @BeiGeneGlobal: Owning the process from clinical trials to manufacturing. The oncology company's CEO sits down with BioCentury Editor in Chief @FishburnSimone to talk company building and what's next for BeiGene buff.ly/3MRnLYR
1
2
536
Simone Fishburn 🎗️ retweeted
13 Sep 2024
We’re inspired by @Immunoplayers in his fireside chat about our joint Together for CHANGE initiative to address data and workforce gaps: "This is a dream project to bring together everyone — all pharma, academic partners are invited to join… First we have to build that trust."
1
3
453
Simone Fishburn 🎗️ retweeted
13 Sep 2024
RGC’s Gonçalo Abecasis lent his insights during an enlightening panel discussion at @BioCentury Grand Rounds on optimizing data for purpose. He shared that at RGC, “We are big believers that genetic variation leads to good therapies.” #BioCenturyGrandRounds 🧬
1
3
5
771
Simone Fishburn 🎗️ retweeted
13 Sep 2024
This Harvard student speaks the truth. “Zionist” is not a slur. @Harvard students need to stop using it as one. @thecrimson thecrimson.com/article/2024/…
2
9
1,039
Simone Fishburn 🎗️ retweeted
6 Sep 2024
Introducting BioCentury's Back to School 2024. Editor in Chief @FishburnSimone and colleagues drill down on picking the right target, and ask can industry solve its biggest bottleneck? buff.ly/4gieu9K
3
2
614
Simone Fishburn 🎗️ retweeted
22 Aug 2024
What a heart-wrenching presentation at the DNC by the parents of Hersh Goldberg-Polin, the young hostage currently being held by Hamas in Gaza.
"There is a surplus of agony on all sides of the tragic conflict in the Middle East. In a competition of pain, there are no winners."
203
253
2,350
141,975
Simone Fishburn 🎗️ retweeted
8 Aug 2024
Building up B cells @Biogen — Jane Grogan discusses her plans for research at the biotech with @FishburnSimone on The #BioCenturyShow buff.ly/3WFM14I
1
1
623
Simone Fishburn 🎗️ retweeted
8 Aug 2024
In an exclusive conversation with @BioCentury, Jim Wilson describes how he plans to use newly launched GemmaBio as a vehicle to create a sustainable model for ultrarare disease gene therapies by capitalizing on efficiencies gained from a platform model. biocentury.com/article/65318…
5
4
731
5 Aug 2024
Calling on translational academics! Do you find it hard to meet #biotech VCs and pharmas? Do you have results and an idea that you'd like to showcase?
BioCentury's Grand Rounds conference is designed for you.
Sept 9-11, Nashville, TN.
Find out more: conferences.biocentury.com/g…
2
2
489
Simone Fishburn 🎗️ retweeted
24 Jul 2024
Greg Verdine, Co-Founder, President & CEO of LifeMine Therapeutics and Professor of Chemistry at Harvard University is joining #BioCenturyGrandRounds to deliver a keynote address: Blowing up the small molecule paradigm.
Learn more: loom.ly/yydzbC8
4
2
808
20 Jul 2024
AZ’s rise in oncology is probably one of biopharma’s all- time top turnaround stories. In this interview with @AstraZeneca oncology head @susanmgalbraith, we discuss what they did: biocentury.com/article/65298…
1
4
459